-
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
31 Jan 2023 23:22 GMT
AMGEN ALSO PROVIDES 2023 GUIDANCE EXCLUDING ANY CONTRIBUTION FROM THE ANNOUNCED ACQUISITION OF HORIZON THERAPEUTICS
THOUSAND OAKS, Calif., Jan. 31, 2023 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter …
-
Lung cancer, free screening to «Pope John»: registrations are underway
25 Jan 2023 11:45 GMT
Pope John XXIII of Bergamo has been given the opportunity to participate in the first national screening program for the early diagnosis of lung cancer
. Subjects between the ages of 55 and 75, heavy smokers or who have quit for less than 15 years and in …
-
Microwave Ablation Market is expected to display a steady growth of 9.8% due to the Rise In Research & Development Activities Among Pharmaceutical Giants| UnivDatos Market Insights
31 Jan 2023 15:47 GMT
… and development. For instance, the National Cancer Institute's budget was approved … patients with primary or secondary lung cancers. It is anticipated that the …
-
Worldwide Cancer Immunotherapy Industry to 2033 - Featuring Novartis, Pfizer, AstraZeneca and Genentech Among Others - ResearchAndMarkets.com
30 Jan 2023 17:26 GMT
The "Cancer Immunotherapy Market by Product, Distribution Channel, Application, End Use, and by Region - Global Forecast to 2022-2033" report has been added to ResearchAndMarkets.com's offering.
The cancer immunotherapy market size is …
-
2023 Atlanta 500: Education & Healthcare
27 Jan 2023 18:47 GMT
Centers for Disease Control and PreventionPhotograph by ShutterstockK-12 | Higher Education | Healthcare | Legends
K-12
Photograph courtesy of individualFrank Brown
CEO
Communities in Schools of Atlanta
As CEO of Communities in Schools of Atlanta, Frank …
-
General electric workers diagnosed with cancer, secure cash benefits from multiple private trusts
27 Jan 2023 15:50 GMT
Plant workers employed before 1981 diagnosed with various cancers are entitled to special benefits. Lung cancer, esophageal cancer, laryngeal cancer, pharyngeal cancer, stomach cancer, colon cancer, rectal cancer, and mesothelioma are frequently caused by …
-
Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications
26 Jan 2023 14:30 GMT
… Consortium (ABRCC); in thoracic/lung cancers, Academic Thoracic Oncology Medical Investigators … been a member of the National Cancer Institute's Investigational Drug Steering …
-
Patient-Focused Drug Development
25 Jan 2023 19:06 GMT
The OCE PFDD program has published multiple manuscripts in peer-reviewed journals to advance patient-focused drug development. Some selected articles are listed below:
Floor and ceiling effects in the EORTC QLQ-C30 Physical Functioning Subscale among …
-
Precigen Announces Positive Phase 1 Dose Escalation and Expansion Cohort Data for Investigational Off-the-Shelf PRGN-2012 AdenoVerse™ Immunotherapy in Patients with Recurrent Respiratory Papillomatosis
25 Jan 2023 06:36 GMT
– Repeated administrations of PRGN-2012 were well-tolerated with no dose-limiting toxicities and no treatment-related adverse events greater than Grade 2 –
– Clinical data show strong response in RRP patients with 50% of patients in Complete Response, …
-
Persistent tumor mutation burden linked with therapeutic response to immunotherapy
26 Jan 2023 19:57 GMT
Cancer experts have tried, sometimes unsuccessfully, to use the total number of mutations in a tumor, called the tumor mutation burden (TMB), to predict a patient's response to immunotherapy. Now, investigators at the Johns Hopkins Kimmel Cancer Center …
About
© 1995-2023